| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.09 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.09 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.08 | 0.1 |